English
Home > Products > PantoprazoleSodiumSesquihydrate API

China PantoprazoleSodiumSesquihydrate API Factory

We have been commitment to supply the competitive price ,excellent products and solutions high-quality, at the same time as fast delivery for PantoprazoleSodiumSesquihydrate API,CAS NO 164579-32-2,164579-32-2, We sincerely hope to determine some satisfactory interactions along with you from the in the vicinity of long run. We're going to hold you informed of our progress and anticipate building steady company relations along with you.
PantoprazoleSodiumSesquihydrate API, Our organization. Situated inside the national civilized cities, the visitors is very easy, unique geographical and economic situations. We pursue a "people-oriented, meticulous manufacturing, brainstorm, construct brilliant" organization. hilosophy. Strict top quality management, fantastic service, reasonable cost in Myanmar is our stand on the premise of competition. If vital, welcome to make contact with us by our web page or telephone consultation, we're planning to be happy to serve you.

Related Products

Hot Products

  • Faropenem sodium

    Faropenem sodium

    Product Name:Faropenem sodium
    Molecular Formula:C12H14NO5S.Na
    Molecular Weight;307.3
    CAS Registry Number;122547-49-3
  • tert-Butylisocyanate

    tert-Butylisocyanate

    Product Name:tert-Butylisocyanate
    Molecular Formula:C5H9NO
    Molecular Weight:99.13
    CAS Registry Number:1609-86-5
  • 4-[4-Bromo-3-(hydroxymethyl)phenoxy]benzonitrile

    4-[4-Bromo-3-(hydroxymethyl)phenoxy]benzonitrile

    Product Name:4-[4-Bromo-3-(hydroxymethyl)phenoxy]benzonitrile
    Molecular Formula:C14H10BrNO2
    Molecular Weight:304.14
    CAS Registry Number:906673-45-8
  • Telmisartan

    Telmisartan

    Product Name:Telmisartan
    Molecular Formula:C33H30N4O2
    Molecular Weight;514.62
    CAS Registry Number;144701-48-4
  • Minoxidil

    Minoxidil

    Product Name:Minoxidil
    Molecular Formula:C9H15N5O
    Molecular Weight;209.25
    CAS Registry Number;38304-91-5
  • Isoxepac

    Isoxepac

    Name:Isoxepac
    Molecular Formula:C16H12O4
    Molecular Weight:268.27
    CAS NO:55453-87-7
    Usage:Olopatadine Hydrochloride
  • Related Blog
  • Reviews

  • Pharmaceutical Intermediates Manufacturers - Something You Need to Know About Pharma Intermediates Industry

    Pharmaceutical intermediates are actually chemical raw materials or chemical products that need to be used in the synthesis of drugs. Such chemical products can be produced in ordinary chemical plants without obtaining a pharmaceutical production license. As long as the technical indicators meet certain level requirements, they can be used to participate in the synthesis and production of drugs.

  • What is the difference between API and FDF in pharma？

    In the pharmaceutical industry, you might hear the terms “FDF” and “API” frequently used in reference to products. We surely understand this type of jargon, but we certainly can see how the general public would feel overwhelmed looking at those kinds of terminology abbreviations. This article is for explaining the difference between API and FDF. For reference, they mean, respectively, “finished dosage form” and “active pharmaceutical ingredient.”

  • TOP 8 Linezolid intermediate maker

    Sandoo Pharmaceuticals and Chemicals Co.,Ltd was established in 2009, with a creative and active team, located in Ningbo, China. We have been specialized in exporting and importing pharmaceutical intermediates and chemical products as well as API for more than 10 years, covering more than 10 countries.

  • Bosutinib CAS 380843-75-4

    Chemical name:4-(2,4-dichloro-5-methoxyanilino)-6-methoxy-7-[3-(4-methylpiperazin-1-yl)propoxy]quinoline-3-carbonitrile

  • Everything You Need To Know About Active Pharmaceutical Ingredients (API In Pharma)

    Sandoo, as a professional API manufactruer in China, we produces a wide range of active pharmaceutical ingredients which can be used in the production of medicines in different applications.

  • Development Trend of China's Pharmaceutical Intermediate Industry

    The rapid development of China's pharmaceutical intermediate industry is closely related to its national policies. Since 2016, China has issued clear documents to encourage small and medium-sized enterprises to develop new drugs, including chemical raw materials. At the same time, the structural upgrading of the pharmaceutical industry in developed countries has promoted the transfer of global related industrial chains and promoted China's chemical raw material drug supply chain. In addition, the increase in Chinese radiography technology has boosted product demand.

Send Inquiry

Hit enter to search or ESC to close
X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept